Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011388:Prolactin / Q000097:blood*; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy*; D011644:Puerperal Disorders / Q000097:blood / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use; D014268:Trifluoperazine / Q000627:therapeutic use
D014150:Antipsychotic Agents; D014268:Trifluoperazine; D011388:Prolactin; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine